While the standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two
doses administered 3 weeks apart, some public health authorities are spacing these doses, …

With the recent approval of highly effective coronavirus disease 2019 (COVID-19) vaccines,
functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS-…

The standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses
administered three weeks apart. However, some public health authorities spaced these …

Spontaneous transcription and translation of HIV can persist during suppressive antiretroviral
therapy (ART). The quantity, phenotype, and biological relevance of this spontaneously "…

Despite advances in COVID-19 management, identifying patients evolving toward death
remains challenging. To identify early predictors of mortality within 60 days of symptom onset (…

Objective Hepatitis E virus (HEV), one of the most common agent of acute hepatitis worldwide,
is mainly transmitted enterically, via contaminated water for HEV genotypes 1 (HEV1) and …

The standard dosing of the Pfizer/BioNTech BNT162b2 mRNA vaccine validated in clinical
trials includes two doses administered three weeks apart. While the decision by some public …

The HIV-1 entry inhibitor temsavir prevents the viral receptor CD4 (cluster of differentiation 4)
from interacting with the envelope glycoprotein (Env) and blocks its conformational changes…

Spacing of BNT162b2 mRNA doses beyond 3 weeks raises concerns about vaccine efficacy.
We longitudinally analyze B cell, T cell, and humoral responses to two BNT162b2 mRNA …

SARS-CoV-2 infection rapidly elicits anti-Spike antibodies whose quantity in plasma gradually
declines upon resolution of symptoms. This decline is part of the evolution of an immune …